Nuwellis, Inc. shared its third-quarter results, showing a 24% smaller operating loss and more console sales.

NUWE · Nuwellis, Inc.

The AI's read

Lower manufacturing costs and reduced spending helped leave more of each sales dollar after production costs. Sales for the first 9 months grew, and console sales rose from 17 to 32, creating more opportunities for repeat circuit sales. Still, quarterly sales stayed flat and the company continued to lose money. Wider pediatric use also depends on FDA clearance, which has not yet been granted.